VNVALUEVNVALUE
Updated weekly
Back to Dashboard
Consumer sector

DBT

Consumer
Công ty Cổ phần Dược phẩm Bến Tre
Y tế/Dược phẩmCT
10.350
VND · Last close
Valuation Verdict
Overvalued
Low
-120%Fair Value+120%
Intrinsic Value
6.199
Current
10.350
Gap
-40.1%
ModelFCF DCF

Valuation Breakdown

CTY tếConsumer
Classified as consumer because ICB sector "Y tế" maps to the consumer group
ModelFCF-Based DCF
Value = Sum of [FCF / (1+WACC)^t] + Terminal Value / (1+WACC)^n

A classic Discounted Cash Flow model built on Free Cash Flow (FCF), the actual cash a business generates after all operating expenses and capital expenditures. Future FCF is projected for 10 years with gradually decaying growth, then discounted back to today's value using WACC. This is the gold standard of intrinsic valuation: it values the company based on what it can actually deliver to shareholders, independent of market sentiment.

Distressed Valuation
Negative Intrinsic Value
BVPS
12.398
x
Discount
50%
=
Floor Value
12.398

Valuation Track Record

Retroactive intrinsic value vs actual close price — DBT

Earnings Quality

Fiscal year 2025

60
Fair
Accrual Quality
94
Cash Conversion
0
Receivables
36
Margin Stability
96
Revenue Quality
100

Financial Forensics

Beneish M-Score · 2025

-2.14
Moderate
DSRI
1.324
GMI
1.013
AQI
0.947
SGI
0.991
DEPI
0.853
SGAI
0.998
TATA
0.015
LVGI
0.989

DBT exhibits a Beneish M-Score of -2.1448, indicating a lower likelihood of earnings manipulation; however, the earnings quality score of 60.1 suggests potential concerns in cash conversion and receivables management. The ownership structure is concentrated among individual shareholders, which may pose governance risks.

Red Flags
  • Earnings Quality Score of 60.1 indicates potential issues with cash conversion (0.0/100) and receivables (35.9/100), suggesting possible liquidity concerns.
  • DSRI of 1.3244 exceeds the threshold of 1.2, indicating potential overstatement of receivables relative to sales.
Positive Signals
  • Beneish M-Score of -2.1448 is below the manipulation threshold of -1.78, suggesting lower likelihood of earnings manipulation.
  • Strong eq_margin score of 96.4/100 and eq_revenue score of 100.0/100 indicate robust profitability and revenue recognition.
Ownership Risk

The top shareholders are individuals with significant stakes, leading to a concentrated ownership structure that may result in governance challenges and potential conflicts of interest.

Recommendation

Investors should closely monitor cash flow and receivables management while considering the potential governance risks associated with concentrated ownership. A thorough review of financial disclosures is recommended before making investment decisions.

Generated by AI based on quantitative data. Not financial advice.

Quantitative Scores

F-Score
4/9
Neutral
Z-Score
1.26
Distress Zone
Sharpe
-0.28
Negative
Composite
43
Weak
Price Risk
Momentum
+0.3%
Volatility
27.9%
Max Drawdown
-14.9%

Key Ratios

Fiscal year 2025
16.20P/E
P/B0.83
P/S0.26
ROE5.2%
ROA1.4%
EPS638.88
BVPS12398.35
Gross Margin39.3%
Net Margin1.6%
D/E2.41
Current Ratio1.12
Rev Growth5.1%
Profit Growth-3.7%
EV/EBITDA11.94
Div Yield0.0%

Company Overview

Issued Shares
22.0M
Charter Capital
219.7B VND
Sector (ICB L2)
Y tế
Industry (ICB L3)
Dược phẩm
Sub-industry
Dược phẩm
Company Type
CT

// OWNERSHIP_NETWORK

> mapping common ownership for DBT — hover nodes for intel, click to navigate

Shareholders
Phạm Thứ Triệu
Indiv
12.6%
1.8 trieu
Lê Cộng Hòa
Indiv
9.0%
1.2 trieu
nguyen-dinh-tu
Indiv
8.1%
1.1 trieu
Bùi Hồng Hạnh
Indiv
7.4%
1.6 trieu
Nguyễn Khắc Hanh
Indiv
5.7%
1.3 trieu
Nguyễn Khắc Hoan
Indiv
5.3%
1.2 trieu
Lê Ngọc Tú
Indiv
5.0%
931.121
Đậu Thị Thúy Mai
Indiv
5.0%
706.520
Lê Trung Hiếu
Indiv
4.9%
656.328
Công ty Cổ Phần Thương Mại Và Rang Xay Cà Phê Việt Nam
Inst
4.8%
1.1 trieu
Công ty TNHH Dược phẩm Tín Đức
Inst
2.7%
188.353
Hoàng Xuân An
Indiv
1.5%
326.555
Công ty CP Cơ Khí Ngân Hàng
Inst
1.5%
180.455
Lê Văn Minh
Indiv
1.3%
190.000
Đinh Văn Bích
Indiv
0.4%
25.410
Dương Thành Đông
Indiv
0.3%
23.600
Nguyễn Thế Quốc Uy
Indiv
0.3%
61.400
Nguyễn Thị Hoàng Oanh
Indiv
0.3%
60.000
Nguyễn Văn Nam
Indiv
0.3%
34.544
Trần Văn Phú
Indiv
0.3%
18.600
Võ Minh Tân
Indiv
0.2%
30.000
Nguyễn Thiện Nhân
Indiv
0.2%
27.000
Trần Thị Thanh Phượng
Indiv
0.2%
25.313
Trương Thị Thúy Nga
Indiv
0.2%
24.620
Nguyễn Văn Nên
Indiv
0.1%
10.020
Nguyễn Thái Dương
Indiv
0.1%
20.000
nguyen-viet-son
Indiv
0.1%
20.000
Nguyễn Văn Hải
Indiv
0.1%
8.166
Nguyễn Thị Thu Hằng
Indiv
0.1%
16.435
Huỳnh Thị Hải Đường
Indiv
0.1%
7.160
Board & Management
Phạm Thứ Triệu12.6%
Tổng Giám đốc
Lê Văn Minh10.7%
Thành viên Ban Kiểm toán nội bộ/Chủ tịch Hội đồng Quản trị
Nguyễn Khắc Hanh5.7%
Phó Tổng Giám đốc/Kế toán trưởng
Hoàng Xuân An1.5%
Phó Tổng Giám đốc
Nguyễn Hoàng Sơn
Thành viên Hội đồng Quản trị
Nguyễn Thị Cấp Tiến
Phụ trách Công bố thông tin
Trần Nguyễn Gia Bảo
Thành viên Hội đồng Quản trị độc lập/Thành viên Ban Kiểm toán nội bộ
Computed 12/04/2026
Methodology & Disclosure

vnvalue is a methodology engine — not an advisor. Every number is the deterministic output of a published formula applied to public financial data. Nothing on this page constitutes investment, financial, legal, or tax advice, nor a recommendation to buy, sell, or hold any security.

All data, models, and outputs are provided AS IS without warranty of any kind. You are solely responsible for your investment decisions. Past performance and historical valuations are not indicative of future results.

By using vnvalue you accept the Terms of Service and Privacy Policy. Full disclaimer →